Premium Content
An Integrated Approach to Rapidly Advancing Poorly Bioavailable Compounds to the Clinic
Dr. Hassan BENAMEUR, Chief Scientific Officer, Small Molecules – Lonza Pharma & Biotech presentation at DDF Summit in Berlin (March 9, 2020).
Published
